You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

51 Results
Guidelines and Advice
Status: Current
ID: GL-C50-20
May 2015
Drug
Other Name(s): Provera® (multiple brands available)
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2015
Regimen
Cancer Type:
Breast, 
Central Nervous System, 
Gastrointestinal, 
Colorectal, 
Esophagus, 
Gastric / Stomach, 
Hepatobiliary / Liver / Bile Duct, 
Pancreas, 
Genitourinary, 
Bladder / Urothelial, 
Prostate, 
Gynecologic, 
Cervix, 
Endometrial, 
Ovary, 
Head and Neck, 
Lung, 
Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
CISplatin,
etoposide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2018
Guidelines and Advice
Status: Current
ID: GL-C50-19
Jan 2015
Cancer facts
Mar 2018
Guidelines and Advice
Status: Current
Version: 1
Mar 2018
Guidelines and Advice
Status: In-Review
ID: 6-13
Mar 2018
Guidelines and Advice
Status: Education and Information
Version: 1
Mar 2018
Guidelines and Advice
Status: Current
ID: N/A
Version: 1
Mar 2018
Statistical Reports
Sep 2015
Statistical Reports
Sep 2015
Guidelines and Advice
Status: In-Review
ID: 19-4
May 2015

Pages